Changes in buprenorphine utilization during the COVID-19 pandemic in the US

Producción científica: Meeting Abstract › revisión exhaustiva

Idioma original	English
Páginas (desde-hasta)	38-39
Publicación	Pharmacoepidemiology and Drug Safety
Volumen	30
Estado	Published - ago 2021

Citar esto

@article{c486adaf573e46599a968ee113c46bc3,

title = "Changes in buprenorphine utilization during the COVID-19 pandemic in the US",

author = "Lindsey Hammerslag and Svetla Slavova and Jeffery Talbert and Walsh, \{Sharon L.\} and Michelle Lofwall and Freeman, \{Patricia R.\}",

year = "2021",

month = aug,

language = "English",

volume = "30",

pages = "38--39",

}

TY - JOUR

T1 - Changes in buprenorphine utilization during the COVID-19 pandemic in the US

AU - Hammerslag, Lindsey

AU - Slavova, Svetla

AU - Talbert, Jeffery

AU - Walsh, Sharon L.

AU - Lofwall, Michelle

AU - Freeman, Patricia R.

PY - 2021/8

Y1 - 2021/8

M3 - Meeting Abstract

SN - 1053-8569

VL - 30

SP - 38

EP - 39

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

ER -